Neurocrine

Neurocrine

Sr. Director, Portfolio Strategy and Analytics

US CA San Diego · Director

Sponsorship not specified$227k-$309kDetected 22 days ago
Data AnalysisStakeholder ManagementBusiness DevelopmentFinancial ModelingForecastingBudgetingValuationERPFDA RegulatoryResearchAnimal StudiesLeadershipCommunicationCollaborationProblem SolvingCritical ThinkingMentoringPublic Speaking

About the role

  • Responsible for leading and advancing enterprise portfolio strategy, optimization, analytics, and resource planning capabilities across Neurocrine's research and development portfolio.
  • Serves as the enterprise subject matter expert for portfolio planning systems, portfolio analytics, and resource optimization methodologies while driving continuous improvement of portfolio management capabilities across the organization. _
  • Your Contributions (include, but are not limited to):

Responsibilities

  • Serves as a strategic advisor to executive leadership, providing data-driven insights and recommendations that support portfolio prioritization, investment decisions, resource allocation, and long-range planning.
  • Partners closely with R&D, Finance, Program Management, Business Development, and Executive Leadership to drive strategic decision-making across discovery, development, and lifecycle programs.
  • Develops and maintains transition probability models across development stages and modalities to support portfolio forecasting, investment planning, and strategic decision-making
  • Leads executive-level portfolio prioritization and trade-off discussions, translating complex portfolio data into actionable recommendations that support portfolio investment and resource allocation decisions
  • Analyzes pipeline progression, development productivity, attrition rates, cycle times, and key portfolio performance indicators to support strategic planning and governance discussions
  • Establishes portfolio data standards, governance processes, and analytics best practices to support high-quality portfolio decision-making
  • Provides analytical support for business development evaluations, external innovation opportunities, and strategic investment assessments
  • Leads cross-functional portfolio planning processes and governance forums to drive alignment, transparency, accountability, and execution excellence

Requirements

  • Master's degree in a related discipline and 12+ years of relevant experience OR
  • PhD, PharmD, MBA, or other advanced degree and 10+ years of relevant experience
  • Expert knowledge of portfolio strategy, portfolio management, resource planning, and investment decision-making frameworks
  • Advanced experience with Planisware or comparable portfolio management and planning platforms
  • Experience implementing, managing, or optimizing portfolio planning systems, analytics capabilities, and governance processes
  • Strong understanding of portfolio valuation, probability of success modeling, scenario planning, forecasting techniques, and portfolio optimization methodologies
  • Experience leading enterprise portfolio planning and prioritization processes across complex, multi-asset development portfolios
  • Experience supporting executive governance committees, portfolio review forums, and strategic planning processes
  • Strong understanding of R&D financial planning, budgeting, forecasting, and resource allocation processes
  • Experience leading portfolio benchmarking and competitive operational analyses

Nice to have

  • Familiarity with AI-enabled analytics tools, advanced modeling techniques, and external benchmarking resources preferred

Skills

  • Evaluates portfolio opportunities, risks, development scenarios, and investment alternatives to maximize overall portfolio value

Compensation

  • Develops portfolio-level financial models supporting annual operating plans, investment prioritization, resource planning, and budget forecasting activities

Company info

  • Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. ( *in collaboration with AbbVie )
  • About the Role:
  • Responsible for leading and advancing enterprise portfolio strategy, optimization, analytics, and resource planning capabilities across Neurocrine's research and development portfolio. Serves as a strategic advisor to executive leadership, providing data-driven insights and recommendations that support portfolio prioritization, investment decisions, resource allocation, and long-range planning. Leads highly complex portfolio planning and analytics activities with significant organizational impact, risk, and complexity. Develops and implements portfolio optimization frameworks, forecasting models, scenario analyses, and decision-support capabilities that enable effective governance and maximize portfolio value. Partners closely with R&D, Finance, Program Management, Business Development, and Executive Leadership to drive strategic decision-making across discovery, development, and lifecycle programs. Serves as the enterprise subject matter expert for portfolio planning systems, portfolio analytics, and resource optimization methodologies while driving continuous improvement of portfolio management capabilities across the organization. _
  • Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs.
  • We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders.
  • The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas.
  • For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions.
  • We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
  • For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. ( *in collaboration with AbbVie )
  • to relieve suffering for people with great needs.
Apply directly at Neurocrine →Create a free account for alerts like thisView Neurocrine immigration profile

This listing is sourced directly from Neurocrine's careers page and normalized into a canonical job model.